KKR & Co. Inc. heads into its May 21 Q1 results with one story dominating the setup: its own executives were aggressive buyers when the stock sold off earlier this year.
Both co-CEOs bought publicly in late February. Joseph Bae and Scott Nuttall each purchased 50,000 shares on February 27, at prices around $88–$88.56, committing roughly $4.4 million apiece. Those purchases followed a cluster of additional buying on February 17 — Nuttall alone put in over $12.8 million across multiple transactions that day. Director Timothy Barakett added 50,000 shares at $94.47 on March 4. Across 90 days, net insider buying totalled more than $50.9 million in value. That's not a token purchase for optics — it's a co-CEO duo putting eight-figure sums into their own stock at levels below where it now trades at $96.97.
Options positioning heading into the print is cautiously defensive, though not at extremes. The put/call ratio has drifted higher in recent weeks, reaching 1.45 — nearly 1.8 standard deviations above the 20-day average of 1.32. That's elevated relative to recent norms, but still well below the 52-week high of 2.18, suggesting measured hedging rather than outright fear. The stock has slipped 5.4% over the past week and is down 24% year-to-date. That context gives the defensive options tilt more meaning — investors are protecting positions in a name that has already given back significant ground.
Short sellers have not pressed their case aggressively. SI stands at just 1.4% of the free float — a low absolute level — even after a 17.7% rise over the past month. Borrow remains nearly free at 0.37% cost to borrow, and the lending market is loose with ample availability. With days to cover under three, there is no real squeeze dynamic in the stock. The short interest trend is worth watching, but it isn't the story.
The analyst community broadly retained constructive ratings after Q4 results on May 6, with UBS lifting its target to $126 and maintaining Buy. RBC and Barclays both trimmed targets modestly while keeping positive ratings. The mean target now sits at $125.80 — roughly 30% above the current price — implying analysts see material upside even after a round of cuts since early April, when Goldman reduced its target from $145 to $110. Bulls point to KKR's diversified fee streams, a growing insurance segment, and demonstrated ability to generate realizations from portfolio companies. Bears focus on macro-driven headwinds to realizations and the dilutive effect of executive stock vesting on per-share earnings. The earnings report is therefore less about the headline number and more about whether management can show that deal activity and insurance earnings are accelerating enough to close the gap between where the stock trades and where its own executives have been buying it.
See the live data behind this article on ORTEX.
Open KKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
